Andrea E. Schwaninger

574 total citations
18 papers, 489 citations indexed

About

Andrea E. Schwaninger is a scholar working on Toxicology, Pharmacology and Clinical Psychology. According to data from OpenAlex, Andrea E. Schwaninger has authored 18 papers receiving a total of 489 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Toxicology, 7 papers in Pharmacology and 7 papers in Clinical Psychology. Recurrent topics in Andrea E. Schwaninger's work include Forensic Toxicology and Drug Analysis (11 papers), Psychedelics and Drug Studies (7 papers) and Pharmacogenetics and Drug Metabolism (6 papers). Andrea E. Schwaninger is often cited by papers focused on Forensic Toxicology and Drug Analysis (11 papers), Psychedelics and Drug Studies (7 papers) and Pharmacogenetics and Drug Metabolism (6 papers). Andrea E. Schwaninger collaborates with scholars based in Germany, United States and Switzerland. Andrea E. Schwaninger's co-authors include Hans H. Maurer, Markus R. Meyer, Josef Zapp, Frank T. Peters, Christian Vollmar, Matthias Bureik, Marilyn A. Huestis, Thomas Kræmer, Călin-Aurel Drăgan and Christoph Sauer and has published in prestigious journals such as Journal of Chromatography A, Clinical Chemistry and Biochemical Pharmacology.

In The Last Decade

Andrea E. Schwaninger

18 papers receiving 480 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andrea E. Schwaninger Germany	14	289	156	136	136	110	18	489
Andreas H. Ewald Germany	16	353 1.2×	98 0.6×	117 0.9×	57 0.4×	120 1.1×	22	508
Christoph Sauer Germany	11	254 0.9×	75 0.5×	116 0.9×	72 0.5×	56 0.5×	14	379
Denis S. Theobald Germany	12	336 1.2×	67 0.4×	164 1.2×	86 0.6×	130 1.2×	15	529
Giselher Fritschi Germany	18	611 2.1×	138 0.9×	264 1.9×	170 1.3×	220 2.0×	23	856
Roland Archer United Kingdom	12	530 1.8×	102 0.7×	352 2.6×	60 0.4×	76 0.7×	13	686
Lilian H.J. Richter Germany	13	262 0.9×	108 0.7×	135 1.0×	63 0.5×	49 0.4×	16	413
Anders Just Pedersen Denmark	10	237 0.8×	101 0.6×	112 0.8×	25 0.2×	80 0.7×	13	390
Maria Katselou Greece	14	195 0.7×	133 0.9×	82 0.6×	37 0.3×	37 0.3×	21	440
Takako Seto Japan	12	291 1.0×	116 0.7×	150 1.1×	51 0.4×	34 0.3×	20	481
John D. Power Ireland	15	404 1.4×	155 1.0×	219 1.6×	14 0.1×	129 1.2×	31	555

Countries citing papers authored by Andrea E. Schwaninger

Since Specialization

Citations

This map shows the geographic impact of Andrea E. Schwaninger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea E. Schwaninger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea E. Schwaninger more than expected).

Fields of papers citing papers by Andrea E. Schwaninger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrea E. Schwaninger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea E. Schwaninger. The network helps show where Andrea E. Schwaninger may publish in the future.

Co-authorship network of co-authors of Andrea E. Schwaninger

This figure shows the co-authorship network connecting the top 25 collaborators of Andrea E. Schwaninger. A scholar is included among the top collaborators of Andrea E. Schwaninger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrea E. Schwaninger. Andrea E. Schwaninger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Schwaninger, Andrea E., Markus R. Meyer, Josef Zapp, & Hans H. Maurer. (2012). Investigations on the stereoselectivity of the phase II metabolism of the 3,4-methylenedioxyethylamphetamine (MDEA) metabolites 3,4-dihydroxyethylamphetamine (DHEA) and 4-hydroxy-3-methoxyethylamphetamine (HMEA). Toxicology Letters. 212(1). 38–47. 5 indexed citations

Schwaninger, Andrea E., Markus R. Meyer, & Hans H. Maurer. (2012). Chiral drug analysis using mass spectrometric detection relevant to research and practice in clinical and forensic toxicology. Journal of Chromatography A. 1269. 122–135. 59 indexed citations

Meyer, Markus R., et al.. (2012). New cathinone‐derived designer drugs 3‐bromomethcathinone and 3‐fluoromethcathinone: studies on their metabolism in rat urine and human liver microsomes using GC–MS and LC–high‐resolution MS and their detectability in urine. Journal of Mass Spectrometry. 47(2). 253–262. 76 indexed citations

Derungs, Adrian, et al.. (2012). Symptoms, toxicities, and analytical results for a patient after smoking herbs containing the novel synthetic cannabinoid MAM-2201. Forensic Toxicology. 31(1). 164–171. 37 indexed citations

Schwaninger, Andrea E., Markus R. Meyer, Marilyn A. Huestis, & Hans H. Maurer. (2011). Development and validation of LC‐HRMS and GC‐NICI‐MS methods for stereoselective determination of MDMA and its phase I and II metabolites in human urine. Journal of Mass Spectrometry. 46(7). 603–614. 28 indexed citations

Meyer, Markus R., J. E. Dinger, Andrea E. Schwaninger, et al.. (2011). Qualitative studies on the metabolism and the toxicological detection of the fentanyl-derived designer drugs 3-methylfentanyl and isofentanyl in rats using liquid chromatography–linear ion trap–mass spectrometry (LC-MSn). Analytical and Bioanalytical Chemistry. 402(3). 1249–1255. 36 indexed citations

Schwaninger, Andrea E., Markus R. Meyer, Allan J. Barnes, et al.. (2011). Stereoselective urinary MDMA (ecstasy) and metabolites excretion kinetics following controlled MDMA administration to humans. Biochemical Pharmacology. 83(1). 131–138. 19 indexed citations

Schwaninger, Andrea E., Markus R. Meyer, Josef Zapp, & Hans H. Maurer. (2011). Sulfation of the 3,4-methylenedioxymethamphetamine (MDMA) metabolites 3,4-dihydroxymethamphetamine (DHMA) and 4-hydroxy-3-methoxymethamphetamine (HMMA) and their capability to inhibit human sulfotransferases. Toxicology Letters. 202(2). 120–128. 22 indexed citations

Schwaninger, Andrea E., Markus R. Meyer, & Hans H. Maurer. (2011). Investigation on the Enantioselectivity of the Sulfation of the Methylenedioxymethamphetamine Metabolites 3,4-Dihydroxymethamphetamine and 4-Hydroxy-3-Methoxymethamphetamine using the Substrate-Depletion Approach. Drug Metabolism and Disposition. 39(11). 1998–2002. 16 indexed citations

10.

Schwaninger, Andrea E., Markus R. Meyer, Allan J. Barnes, et al.. (2011). Urinary Excretion Kinetics of 3,4-Methylenedioxymethamphetamine (MDMA, Ecstasy) and Its Phase I and Phase II Metabolites in Humans following Controlled MDMA Administration. Clinical Chemistry. 57(12). 1748–1756. 25 indexed citations

11.

Schwaninger, Andrea E., Markus R. Meyer, & Hans H. Maurer. (2010). Gas Chromatography-Mass Spectrometry Detection of a Norfluoxetine Artifact in Hydrolyzed Urine Samples May Falsely Indicate Tranylcypromine Ingestion. Journal of Analytical Toxicology. 34(1). 45–48. 2 indexed citations

12.

Drăgan, Călin-Aurel, Frank T. Peters, Pierre Bour, et al.. (2010). Convenient Gram-Scale Metabolite Synthesis by Engineered Fission Yeast Strains Expressing Functional Human P450 Systems. Applied Biochemistry and Biotechnology. 163(8). 965–980. 55 indexed citations

13.

Drăgan, Călin-Aurel, et al.. (2010). Whole-cell biotransformation assay for investigation of the human drug metabolizing enzyme CYP3A7. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1814(1). 161–167. 21 indexed citations

14.

Peters, Frank T., Andrea E. Schwaninger, Christoph Sauer, et al.. (2009). Use of fission yeast heterologously expressing human cytochrome P450 2B6 in biotechnological synthesis of the designer drug metabolite N-(1-phenylcyclohexyl)-2-hydroxyethanamine. Forensic Science International. 184(1-3). 69–73. 18 indexed citations

15.

Peters, Frank T., et al.. (2009). Biotechnological Synthesis of the Designer Drug Metabolite 4'-Hydroxymethyl- -pyrrolidinohexanophenone in Fission Yeast Heterologously Expressing Human Cytochrome P450 2D6--A Versatile Alternative to Multistep Chemical Synthesis. Journal of Analytical Toxicology. 33(4). 190–197. 22 indexed citations

16.

Schwaninger, Andrea E., Markus R. Meyer, Josef Zapp, & Hans H. Maurer. (2009). The Role of Human UDP-Glucuronyltransferases on the Formation of the Methylenedioxymethamphetamine (Ecstasy) Phase II Metabolites R- and S-3-Methoxymethamphetamine 4-O-Glucuronides. Drug Metabolism and Disposition. 37(11). 2212–2220. 27 indexed citations

17.

Sauer, Christoph, Frank T. Peters, Andrea E. Schwaninger, Markus R. Meyer, & Hans H. Maurer. (2008). Investigations on the cytochrome P450 (CYP) isoenzymes involved in the metabolism of the designer drugs N-(1-phenyl cyclohexyl)-2-ethoxyethanamine and N-(1-phenylcyclohexyl)-2-methoxyethanamine. Biochemical Pharmacology. 77(3). 444–450. 11 indexed citations

18.

Sauer, Christoph, Frank T. Peters, Andrea E. Schwaninger, Markus R. Meyer, & Hans H. Maurer. (2008). Identification of Cytochrome P450 Enzymes Involved in the Metabolism of the Designer DrugsN-(1-Phenylcyclohexyl)-3-ethoxypropanamine andN-(1-Phenylcyclohexyl)-3-methoxypropanamine. Chemical Research in Toxicology. 21(10). 1949–1955. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact